Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 308-310, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Drayer, D. E.
Right arrow Articles by Reidenberg, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Drayer, D. E.
Right arrow Articles by Reidenberg, M. M.

Clinical Chemistry, Vol 27, 308-310, Copyright © 1981 by American Association for Clinical Chemistry

Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum

DE Drayer, B Lorenzo and MM Reidenberg

Sera from 67 cardiac patients being treated with quinidine were analyzed for this drug by both a homogeneous enzyme immunoassay (EMIT) and a fluorescence procedure (double-extraction method). Of these samples, 47 were also analyzed for quinidine and its major metabolite in serum, (3s)-3-hydroxyquinidine, by liquid chromatography. Results by the EMIT procedure correlated well with those by both the chromatographic and fluorescence procedures, but EMIT gave, on the average, 25% higher values for quinidine than did the chromatographic procedure. The EMIT procedure is therefore not totally specific. (3s)-3- Hydroxyquinidine and dihydroquinidine (a contaminant present in standard quinidine formulations) each show cross reactivity in the EMIT assay for quinidine. Nevertheless, the EMIT assay for quinidine is acceptable for clinical use because these two compounds are also pharmacologically active.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.